• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: February 14-18


ICYMI, this week we had stories on the possible association between psoriasis and colorectal cancer, limiting skin cancer risk, and more.

POLL: Are your patients still using telehealth?

Topical JAK Inhibitors for Atopic Dermatitis

A review of topical JAK inhibitor ruxolitinib.

Study: Psoriasis BSA Correlation to Patient Increase for Cosmetic Procedures

A recent study examined the link between psoriasis clearance, quality of life, and an uptick in cosmetic procedures.

The Mainstream Patient: February 14

This week's edition of the Mainstream Patients features stories about forgotten about symptoms of Crohn's Disease--like skin inflammation, foods to avoid to help inflammation, what 'slugging' the newest skin care trend is, and more.

Study: Psoriasis and Colorectal Cancer Association

An article the in Journal of the American Academy of Dermatology examined the possible connection between psoriasis and colorectal cancer.

An In-depth Guide to a Medical Practice's Legal and Tax Options

We sit down with the experts to determine what legal and tax factors come into play when deciding on the best corporate structure for a dermatology practice.

AAD Highlights Care for Dry, Cracked Heels

The American Academy of Dermatology released tips on how to treat dry, cracked heels including limited bath times, using a gentle, fragrance-free cleanser, and more.

Few hospitals complying with price transparency law

Just 14.3% of hospitals complying with rule meant to encourage consumer price shopping

Timber Pharmaceuticals Meets with FDA on TMB-001 End-of-Phase 2 Trial

Timber Pharmaceuticals announced a positive end-of-phase 2 meeting with the FDA about TMB-001 in moderate to severe congenital ichthyosis. Timber also revealed when it plans to start a phase 3 trial.

Pointers with Dr Portela: Screen Break by Addison Rae

In this week’s Pointers with Dr Portela, the 208SkinDoc dives into the newest attempt at blue light protecting skin care, providing a full review of the products, its ingredients, and if there is any science behind its claims.

PCA Skin Heads to the International Space Station

The company announced plans to send the first-ever private sector skin health experiment to the International Space Station.

69% of Patients Would Switch Providers for Better Services

Report shows public’s desire for more convenience and empathy.

The Cutaneous Connection: Diving Into the Aesthetics Industry

This episode of The Cutaneous Connection podcast dives into the aesthetic industry, highlighting stackable aesthetic treatments, how the aesthetic world has changed in the last 10 years, and how allied health care workers should be utilized in the practice.

Robert Califf Confirmed as New Head of FDA

Robert M. Califf, MD, MACC, was approved in a 50-46 vote by the senate.

Miiskin Platform Adds Remote Refill Access

The skin tracking platform by Miiskin has added a new feature that allowed users to submit prescription requests virtually.

Health Care Workers See Massive 249% Surge in Injury and Illness Rates

Health care and social workers combined for more injuries and illnesses than any other industry in the nation.

Almirall Launches Wynzora Cream for Plaque Psoriasis in Europe

The calcipotriene and betamethasone dipropionate cream is for the treatment of mild to moderate plaque psoriasis in adult patients, including the scalp.

Disease Awareness Remains Key Limitation in Hyperhidrosis Market

A report from GlobalData reports that the main barrier to growth in the United States axillary hyperhidrosis market is limited disease awareness.

Study: Knowing Skin Cancer Risk May Limit Unhealthy Behavior

The Mayo Clinic recently published a study examining the part of risk perception in curbing behavior that increases the risk of future melanoma.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.